NCT00003534 2018-01-31
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT01260103 2017-07-26
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Burzynski Research Institute
Phase 3 Withdrawn
NCT00003455 2013-07-10
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003486 2013-07-10
Antineoplaston Therapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003502 2013-07-10
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn